Cargando…
The Role of Gut Bacteria and Fungi in Alcohol-Associated Liver Disease
Cirrhosis and liver cancer caused by alcohol-associated liver disease (ALD) are serious threats to people's health. In addition to hepatic cell apoptosis and liver inflammation caused by oxidative stress during alcohol metabolism, intestinal microbiota disorders are also involved in the onset a...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927088/ https://www.ncbi.nlm.nih.gov/pubmed/35308525 http://dx.doi.org/10.3389/fmed.2022.840752 |
_version_ | 1784670374690029568 |
---|---|
author | Chen, Liuying Zhu, Yixin Hou, Xiaohua Yang, Ling Chu, Huikuan |
author_facet | Chen, Liuying Zhu, Yixin Hou, Xiaohua Yang, Ling Chu, Huikuan |
author_sort | Chen, Liuying |
collection | PubMed |
description | Cirrhosis and liver cancer caused by alcohol-associated liver disease (ALD) are serious threats to people's health. In addition to hepatic cell apoptosis and liver inflammation caused by oxidative stress during alcohol metabolism, intestinal microbiota disorders are also involved in the onset and development of ALD. Ethanol and its' oxidative and non-oxidative metabolites, together with dysbiosis-caused-inflammation, destroys the intestinal barrier. Changes of several microbial metabolites, such as bile acids, short-chain fatty acids, and amino acid, are closely associated with gut dysbiosis in ALD. The alcohol-caused dysbiosis can further influence intestinal barrier-related proteins, such as mucin2, bile acid-related receptors, and aryl hydrocarbon receptor (AhR), and these abnormal changes also participate in the injury of the intestinal barrier and hepatic steatosis. Gut-derived bacteria, fungi, and their toxins, such as lipopolysaccharide (LPS) and β-glucan translocate into the liver through the damaged intestinal barrier and promote the progression of inflammation and fibrosis of ALD. Thus, the prevention of alcohol-induced disruption of intestinal permeability has a beneficial effect on ALD. Currently, multiple therapeutic treatments have been applied to restore the gut microbiota of patients with ALD. Fecal microbial transplantation, probiotics, antibiotics, and many other elements has already shown their ability of restoring the gut microbiota. Targeted approaches, such as using bacteriophages to remove cytolytic Enterococcus faecalis, and supplement with Lactobacillus, Bifidobacterium, or boulardii are also powerful therapeutic options for ALD. |
format | Online Article Text |
id | pubmed-8927088 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89270882022-03-18 The Role of Gut Bacteria and Fungi in Alcohol-Associated Liver Disease Chen, Liuying Zhu, Yixin Hou, Xiaohua Yang, Ling Chu, Huikuan Front Med (Lausanne) Medicine Cirrhosis and liver cancer caused by alcohol-associated liver disease (ALD) are serious threats to people's health. In addition to hepatic cell apoptosis and liver inflammation caused by oxidative stress during alcohol metabolism, intestinal microbiota disorders are also involved in the onset and development of ALD. Ethanol and its' oxidative and non-oxidative metabolites, together with dysbiosis-caused-inflammation, destroys the intestinal barrier. Changes of several microbial metabolites, such as bile acids, short-chain fatty acids, and amino acid, are closely associated with gut dysbiosis in ALD. The alcohol-caused dysbiosis can further influence intestinal barrier-related proteins, such as mucin2, bile acid-related receptors, and aryl hydrocarbon receptor (AhR), and these abnormal changes also participate in the injury of the intestinal barrier and hepatic steatosis. Gut-derived bacteria, fungi, and their toxins, such as lipopolysaccharide (LPS) and β-glucan translocate into the liver through the damaged intestinal barrier and promote the progression of inflammation and fibrosis of ALD. Thus, the prevention of alcohol-induced disruption of intestinal permeability has a beneficial effect on ALD. Currently, multiple therapeutic treatments have been applied to restore the gut microbiota of patients with ALD. Fecal microbial transplantation, probiotics, antibiotics, and many other elements has already shown their ability of restoring the gut microbiota. Targeted approaches, such as using bacteriophages to remove cytolytic Enterococcus faecalis, and supplement with Lactobacillus, Bifidobacterium, or boulardii are also powerful therapeutic options for ALD. Frontiers Media S.A. 2022-03-03 /pmc/articles/PMC8927088/ /pubmed/35308525 http://dx.doi.org/10.3389/fmed.2022.840752 Text en Copyright © 2022 Chen, Zhu, Hou, Yang and Chu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Chen, Liuying Zhu, Yixin Hou, Xiaohua Yang, Ling Chu, Huikuan The Role of Gut Bacteria and Fungi in Alcohol-Associated Liver Disease |
title | The Role of Gut Bacteria and Fungi in Alcohol-Associated Liver Disease |
title_full | The Role of Gut Bacteria and Fungi in Alcohol-Associated Liver Disease |
title_fullStr | The Role of Gut Bacteria and Fungi in Alcohol-Associated Liver Disease |
title_full_unstemmed | The Role of Gut Bacteria and Fungi in Alcohol-Associated Liver Disease |
title_short | The Role of Gut Bacteria and Fungi in Alcohol-Associated Liver Disease |
title_sort | role of gut bacteria and fungi in alcohol-associated liver disease |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927088/ https://www.ncbi.nlm.nih.gov/pubmed/35308525 http://dx.doi.org/10.3389/fmed.2022.840752 |
work_keys_str_mv | AT chenliuying theroleofgutbacteriaandfungiinalcoholassociatedliverdisease AT zhuyixin theroleofgutbacteriaandfungiinalcoholassociatedliverdisease AT houxiaohua theroleofgutbacteriaandfungiinalcoholassociatedliverdisease AT yangling theroleofgutbacteriaandfungiinalcoholassociatedliverdisease AT chuhuikuan theroleofgutbacteriaandfungiinalcoholassociatedliverdisease AT chenliuying roleofgutbacteriaandfungiinalcoholassociatedliverdisease AT zhuyixin roleofgutbacteriaandfungiinalcoholassociatedliverdisease AT houxiaohua roleofgutbacteriaandfungiinalcoholassociatedliverdisease AT yangling roleofgutbacteriaandfungiinalcoholassociatedliverdisease AT chuhuikuan roleofgutbacteriaandfungiinalcoholassociatedliverdisease |